Response to Commentaries

William P Horan; Amir Kalali; Stephen K Brannan; Wayne Drevets; Atul Mahableshwarkar; Srinivas Rao; Corey Reuteman-Fowler; Adam Savitz; Jaskaran Singh; Gary Walker; Jens R Wendland; Philip D Harvey

doi:10.1093/schbul/sbae227

Back

Journal article

Open access

Peer reviewed

Response to Commentaries

William P Horan, Amir Kalali, Stephen K Brannan, Wayne Drevets, Atul Mahableshwarkar, Srinivas Rao, Corey Reuteman-Fowler, Adam Savitz, Jaskaran Singh, Gary Walker, …

Schizophrenia bulletin

2025-01-25

DOI: https://doi.org/10.1093/schbul/sbae227

PMID: 39862390

Appears in Miller School of Medicine - Latest Publications

Files and links (1)

url

https://doi.org/10.1093/schbul/sbae227View

Published (Version of record) Open

Metrics

1 Record Views

Details

Title: Response to Commentaries
Creators: William P Horan - Bristol-Myers Squibb
Amir Kalali - Society for International Development
Stephen K Brannan - Johnson & Johnson
Wayne Drevets - Johnson & Johnson
Atul Mahableshwarkar - Cybin IRL, Cambridge, MA 02138, United States
Srinivas Rao - PAI Life Sciences
Corey Reuteman-Fowler - Boehringer Ingelheim
Adam Savitz - Alto Neuroscience
Jaskaran Singh - Neurocrine Biosciences
Gary Walker - Recognify Life Sciences, South San Francisco, CA 94080, United States
Jens R Wendland - Kynexis Therapeutics, Cambridge, MA 02138, United States
Philip D Harvey - University of Miami
Publication Details: Schizophrenia bulletin
Academic Unit: Miller School of Medicine; UMMG Dept of Psychiatry & Behavioral Sciences
Language: English
Resource Type: Journal article
PMID: 39862390
Record Identifier: 991032547487202976